Editorial| Volume 132, ISSUE 1, P6-8, July 1998

Drug combinations: From laboratory to practice

      This paper is only available as a PDF. To read, Please Download here.


      CI (combination index for quantifying synergism additive effect antagonism), DRI (dose-reduction index), MEP (median-effect principle plot), Isobol (isobologram for equi-effect graphics for two drug doses)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Chou T-C
        • Talalay P
        Analysis of combined drug effects: a new look at a very old problem.
        Trends Pharmacol Sci. 1983; 4: 450-454
        • Chou T-C
        The median-effect principle and the combination index for quantitation of synergism and antagonism.
        in: Chou T-C Rideout D Synergism and antagonism in chemotherapy. Academic Press, San Diego1991: 61-102
        • Chou T-C
        • Rideout D
        • Chou JH
        • Bertino JR
        Chemotherapeutic synergism, potentiation and antagonism. 2nd ed. Encyclopedia of human biology. vol 2. Academic Press, San Diego1997: 675-683
        • Chou T-C
        • Motzer RJ
        • Tong Y
        • Bosl GJ
        Computerized quantitation of synergism and antagonism of taxol, topotecan and cisplatin against teratocarcinoma cell growth: a rational approach to clinical protocol design.
        J Natl Cancer Inst. 1994; 86: 1517-1524
        • Bertino JR
        • Chou T-C
        Chemotherapy: synergism and antagonism. 2nd ed. Encyclopedia of cancer. vol 1. Academic Press, San Diego1997: 368-379
        • Guo J
        • Reidenberg MM
        Inhibition of 11-β hydroxysteroid dehydrogenase by bioflavonoids and their interaction with furosemide and gossypol.
        J Lab Clin Med. 1998; 131: 32-38
      1. Permuterm Subject Index, Science Citation Index. Institute for Scientific Information, Philadelphia1997
        • Goldin A
        • Mantel N
        The employment of combinations of drugs in the chemotherapy of neoplasia: a review.
        Cancer Res. 1957; 17: 635-654
        • Berenbaum MC
        What is synergy?.
        Pharmacol Rev. 1989; 41: 93-141
        • Chou T-C
        • Talalay P
        Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.
        Adv Enzyme Regul. 1984; 22: 27-55
        • Chou T-C
        Relationships between inhibition constants and fractional inhibitions in enzyme-catalyzed reactions with different numbers of reactants, different reaction mechanisms, and different types of mechanisms of inhibition.
        Mol Pharmacol. 1974; 10: 235-247
        • Chou T-C
        Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands.
        J Theor Biol. 1996; 39: 253-276
        • Chou T-C
        • Talalay P
        Generalized equations for the analysis of inhibitors of Michaelis-Menten and higher order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors.
        Eur J Biochem. 1981; 115: 207-216
        • Chou T-C
        • Talalay P
        Applications of the median-effect principle for the assessment of low-dose risk of carcinogens and for the quantitation of synergism and antagonism of chemotherapeutic agents.
        in: Harrap KR Connors TA New Avenues of developmental cancer chemotherapy. 2nd ed. Bristol-Myers Symposium series. Academic Press, New York1987: 37-64
        • Chou J
        • Chou T-C
        Dose-effect analysis with microcomputers: quantitation of ED50, LD50, synergism, antagonism, low-dose risk, receptor-ligand binding and enzyme kinetics.
        in: Manual and software. Biosoft, Cambridge, England1987
        • Chou T-C
        • Hayball M
        CalcuSyn for Windows, multiple-drug dose-effect analyzer and manual.
        Biosoft, Cambridge, England1996
        • Loewe S
        Antagonism and antagonist.
        Pharmacol Rev. 1957; 9: 237-242
        • Berenbaum MC
        Synergy, additivism and antagonism in immunosupression: a critical review.
        Clin Exp Immunol. 1977; 28: 1-18
        • Webb JL
        2nd ed. Enzyme metabolic inhibitors. vol 1. Academic Press, New York1963: 55-79
      2. Science Citation Index. Institute for Scientific Information, Philadelphia1998 (1983–1998)